Very ‘decent’ sales performances of listed pharmaceutical companies in first half

Listed pharmaceutical companies’ sales performances were evaluated as decent in the first half of the year.

Their sales growth rate was above 10%, their profit growth rate reached 30%, and their net profits were also increased by more than 40%. They were able to catch two hares called sales and profits at once.

According to the Yakup Shinmoon’s(www.yakup.com) analysis report of KOSPI and KOSD...